Story perspectives

GSK and Cognizant Deploy 40 AI Agents to Cut Safety Reporting Time 50%

By Drooid · Oct 25, 2026, 11:28 PM UTC · How we work

Summary

Story summary

GSK and Cognizant are deploying about 40 specialized AI agents to automate the drug-safety reporting lifecycle.
The AI system will classify reports, prioritize them, and route them to specialists, aiming to cut processing time by 50 percent.
GSK targets a 40 percent reduction in signal-to-decision interval and >90 percent quality-control consistency, while building audit trails and enabling citizen-development workflows.

1 of 1

Story summary

GSK and Cognizant are deploying about 40 specialized AI agents to automate the drug-safety reporting lifecycle.
The AI system will classify reports, prioritize them, and route them to specialists, aiming to cut processing time by 50 percent.
GSK targets a 40 percent reduction in signal-to-decision interval and >90 percent quality-control consistency, while building audit trails and enabling citizen-development workflows.